Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2026-01-03 @ 3:04 PM
Study NCT ID:
NCT01023958
Status:
COMPLETED
Last Update Posted:
2017-11-22
First Post:
2009-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer
Sponsor:
Boehringer Ingelheim
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1230.2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None